Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients

References

1. 1.↵
   1. O'Sullivan BP,
   2. Freedman SD

   . Cystic fibrosis. Lancet 2009;373(9678):1891–1904.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Kerem E

   . Cystic fibrosis: priorities and progress for future therapies. Paediatr Respir Rev 2017;24:14–16.

   OpenUrl
3. 3.↵
   1. Flume PA,
   2. O'Sullivan BP,
   3. Robinson KA,
   4. Goss CH,
   5. Mogayzel PJ,
   6. Willey-Courand DB,
   7. et al

   . Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176(10):957–969.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Mogayzel PJ,
   2. Naureckas ET,
   3. Robinson KA,
   4. Mueller G,
   5. Hadjiliadis D,
   6. Hoag JB,
   7. et al

   . Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2013;187(7):680–689.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Smyth AR,
   2. Bell SC,
   3. Bojcin S,
   4. Bryon M,
   5. Duff A,
   6. Flume P,
   7. et al

   . European Cystic Fibrosis Society standards of care: best practice guidelines. J Cyst Fibros 2014;13(Suppl 1):S23–S42.

   OpenUrlPubMed
6. 6.↵
   1. Bauer A,
   2. McGlynn P,
   3. Bovet LL,
   4. Mims PL,
   5. Curry LA,
   6. Hanrahan JP

   . Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution. Respir Care 2009;54(10):1342–1347.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Smith EC,
   2. Denyer J,
   3. Kendrick AH

   . Comparison of twenty-three nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995;8(7):1214–1221.

   OpenUrlAbstract
8. 8.↵
   1. Reisner C,
   2. Katial RK,
   3. Bartelson BB,
   4. Buchmeir A,
   5. Rosenwasser LJ,
   6. Nelson HS

   . Characterization of aerosol output from various nebulizer/compressor combinations. Ann Allergy Asthma Immunol 2001;86(5):566–574.

   OpenUrlPubMedWeb of Science
9. 9.↵
   1. Awad S,
   2. Williams DK,
   3. Berlinski A

   . Longitudinal evaluation of compressor/nebulizer performance. Respir Care 2014;59(7):1053–1061.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    TOBI [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation 2009.
11. 11.↵
    Pulmozyme [package insert]. South San Francisco, CA: Genetech, Inc. 2014.
12. 12.↵
    1. Standaert TA,
    2. Bohn SE,
    3. Aitken ML,
    4. Ramsey B

    . The equivalence of compressor pressure-flow relationships with respect to jet nebulizer aerosolization characteristics. J Aerosol Med 2001;14(1):31–42.

    OpenUrlPubMed
13. 13.↵
    1. Berlinski A,
    2. Hayden JB

    . Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor. J Aerosol Med Pulm Drug Deliv 2010;23(6):397–404.

    OpenUrlPubMed
14. 14.↵
    1. Chavez A,
    2. McCracken A,
    3. Berlinski A

    . Effect of face mask dead volume, respiratory rate, and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010;45(3):224–229.

    OpenUrlPubMed
15. 15.↵
    1. Melani AS

    . Effects on aerosol performance of mixing of either budesonide or beclomethasone dipropionate with albuterol and ipratropium bromide. Respir Care 2011;56(3):319–326.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. de Boer AH,
    2. Hagedoorn P,
    3. Frijlink HW

    . The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the Pari LC PLUS reusable nebuliser. Int J Pharm 2003;268(1-2):59–69.

    OpenUrlPubMed
17. 17.↵
    1. Berg EB,
    2. Picard RJ

    . In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns. Respir Care 2009;54(12):1671–1678.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Standaert TA,
    2. Vandevanter D,
    3. Ramsey BW,
    4. Vasiljev M,
    5. Nardella P,
    6. Gmur D,
    7. et al

    . The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer. J Aerosol Med 2000;13(2):147–153.

    OpenUrlPubMed
19. 19.↵
    1. Westerman EM,
    2. Boer AH,
    3. Touw DJ,
    4. Brun PP,
    5. Roldaan AC,
    6. Frijlink HW,
    7. Heijerman HG

    . Aerosolization of tobramycin (TOBI) with the Pari LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor. J Aerosol Med Pulm Drug Deliv 2008;21(3):269–280.

    OpenUrlPubMed
20. 20.↵
    1. Fiel SB,
    2. Fuchs HJ,
    3. Johnson C,
    4. Gonda I,
    5. Clark AB

    . Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. Chest 1995;108(1):153–156.

    OpenUrlCrossRefPubMed